Core Insights - Zuellig Pharma has launched a new Clinical Trial Support Innovation Center in South Korea, which is positioned to be the most advanced automated hub for clinical logistics in the country, enhancing its role in global clinical research [1][2] Company Overview - Zuellig Pharma is a leading healthcare solutions provider in Asia, with a mission to improve healthcare accessibility across the region. The company has a century-long history and operates in 18 markets, employing over 12,000 staff and serving more than 200,000 medical facilities [11] Facility Details - The new facility spans 3,800 square meters and is strategically located near the Gyeongbu Expressway in Gyeonggi-do province. It aims to set new standards in clinical trial logistics through automation, digitalization, and compliance with Good Practice (GxP) [3][4] - Equipped with advanced capabilities, the facility features a fully automated order fulfillment system, enhancing the speed, accuracy, and reliability of clinical supply delivery [5] - The center supports comprehensive temperature-zone management for thousands of unique clinical trial SKUs, ensuring precise handling of temperature-sensitive products throughout the supply chain [6] Operational Impact - The facility's specialized repackaging infrastructure is designed to meet stringent clinical and regulatory standards, ensuring product integrity during the clinical trial lifecycle. It includes an integrated tracking and monitoring system for full chain-of-custody and compliance [7] - Over the past year, the center has supported more than 3,000 studies in collaboration with over 100 clients, managing approximately 13,000 outbound shipments annually, including various therapeutic products [9] Market Position - As of 2025, South Korea ranks among the top 10 clinical trial markets globally and has the third-largest number of R&D pipelines. The new facility is built to meet the rising demand for clinical trial support, aiming to improve patient access and outcomes worldwide [8]

Core Insights - Medidata has been recognized as a Leader in Everest Group's Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025, supporting over 1 million patients and reducing study build timelines by up to 50% compared to industry standards [1][2][3] Company Overview - Medidata, a brand of Dassault Systèmes, has been a leader in the eCOA market for over a decade, providing foundational solutions for thousands of global studies across various indications [2][4] - The company has celebrated 25 years of technological innovation, supporting over 36,000 trials and 11 million patients, with more than 1 million registered users across approximately 2,300 customers [6] Product Innovations - Medidata eCOA combines advanced technology and operational expertise to launch studies faster than the industry standard, maintaining top data integrity and reducing study build time by up to six weeks compared to the standard of 12 or more weeks [2][4] - Recent partnerships, such as with Cogstate, have enhanced Medidata eCOA with scientific rigor aimed at reducing rater burden and improving signal detection in Central Nervous System (CNS) trials [2] Industry Impact - Medidata's consistent recognition by Everest Group in 2023 and 2024 for Decentralized Clinical Trials highlights its leadership in improving clinical trial operations and accelerating the delivery of life-saving therapies to market [4][6] - The company's commitment to delivering expert advisory and scientific support services contributes to trial success, higher quality data, and superior experiences for patients and sites [2][3]

Core Insights - Veeva Systems has announced a collaboration with Amgen to enhance clinical trial innovation, utilizing the Veeva Clinical Platform to improve efficiencies in the clinical trial process [1][2][3] Group 1: Collaboration Details - Amgen aims to leverage advanced technology through this collaboration to enhance its end-to-end trial operations, which is expected to expedite the delivery of innovative treatments to patients [2] - The Veeva Clinical Platform will serve as the backbone for standardized and connected processes, facilitating faster delivery of life-saving drugs [3] Group 2: Veeva Clinical Platform Overview - The Veeva Clinical Platform is a comprehensive and connected solution that encompasses various clinical operations and data applications, including CTMS, EDC, clinical workbench, RTSM, eCOA, eTMF, and more [4] - This platform is designed to streamline clinical trials from initiation to completion, automating data flow and enhancing operational efficiency [4] Group 3: Company Background - Veeva Systems provides industry-specific cloud solutions for life sciences, serving over 1,500 customers, including major biopharmaceutical companies and emerging biotech firms [5] - The company is committed to innovation, product excellence, and balancing the interests of all stakeholders, including customers, employees, and shareholders [5]